Our Molecular Oncology Laboratory is fully staffed by a team of highly experienced molecular scientists and pathologists and equipped with state-of-the-art technology including Next Generation Sequencing (NGS) or multiplex hybridization-based platforms.
PRINCIPAL PLATFORMS USED:
We have developed highly sensitive and specific diagnostic tests using alternative biosources such as blood. This overcomes the challenges associated with obtaining sufficient tumor material for genetic analyses and makes serial treatment monitoring and early detection of therapy resistance a reality in personalized cancer treatment. We are one of the leading European providers in the field of liquid biopsies and the first pharmacogenomics laboratory in Spain to be accredited, by the National Accreditation Body (ENAC), ISO 15189, to perform genetic testing for cancer patients in liquid biopsy samples (nº 750/LE1556).
Our experience is endorsed by the numerous clinical trials in which we were selected as a reference laboratory.